|
Miyazawa K, Kondo Y, Nakano M, Esteve-Pastor MA, Rivera-Caravaca JM, Senoo K, Kobayashi Y, Lip GYH. Risk factors for the development of incident atrial fibrillation in patients with cardiac implantable electronic devices. Eur J Intern Med. 2018 Jun;52:54-59. doi: 10.1016/j.ejim.2018.02.019. Epub 2018 Mar 2. PubMed PMID: 29490874.
AÑO: 2018; IF: 3.66
|
29490874
|
Carrillo-Aleman L, Marin F, Rivera-Caravaca JM, Vicente-Ibarra N, Candela-Sanchez E, Esteve-Pastor MA, Lozano T, Sandin-Rollan M, Pernias-Escrig V, Macias M, Quintana-Giner M, Veliz A, Orenes-Pinero E, Martinez-Martinez JG, Ruiz-Nodar JM. Switching of Oral P2Y12 Inhibitor Treatment in Patients with Acute Coronary Syndrome: Prevalence, Predictors, and Prognosis. Clin Drug Investig. 2019 Mar;39(3):275-283. doi: 10.1007/s40261-018-0736-z. PubMed PMID: 30623372.
AÑO: 2019; IF: 2.267
|
|
Rivera-Caravaca JM, Marin F, Vilchez JA, Galvez J, Esteve-Pastor MA, Vicente V, Lip GYH, Roldan V. Refining Stroke and Bleeding Prediction in Atrial Fibrillation by Adding Consecutive Biomarkers to Clinical Risk Scores. Stroke. 2019 Jun;50(6):1372-1379. doi: 10.1161/STROKEAHA.118.024305. Epub 2019 May 14. PubMed PMID: 31084333.
AÑO: 2019; IF: 10.17
|
|
Orenes-Pinero E, Esteve-Pastor MA, Ruiz-Nodar JM, Quintana-Giner M, Veliz-Martinez A, Tello-Montoliu A, Macias-Villanego MJ, Pernias-Escrig V, Vicente-Ibarra N, Carrillo-Aleman L, Sandin-Rollan M, Martinez J, Lozano T, Rivera-Caravaca JM, Marin F. Under-prescription of novel antiplatelet drugs in patients with acute coronary syndrome and previous cardiovascular disease. Minerva Med. 2019 Oct;110(5):410-418. doi: 10.23736/S0026-4806.19.05859-2. Epub 2019 May 6. PubMed PMID: 31081301.
AÑO: 2019; IF: 3.031
|
|
Esteve-Pastor MA, Roldan V, Rivera-Caravaca JM, Ramirez-Macias I, Lip GYH, Marin F. The Use of Biomarkers in Clinical Management Guidelines: A Critical Appraisal. Thromb Haemost. 2019 Dec;119(12):1901-1919. doi: 10.1055/s-0039-1696955. Epub 2019 Sep 9. PubMed PMID: 31499565.
AÑO: 2019; IF: 4.385
|